C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2002
10/22/2002	CA2022437C Reduced size lhrh analogs
10/22/2002	CA1341395C Preparation of functional human factor viii
10/21/2002	EP1147184A4 Controlled expression of heterologous proteins in the mammary gland of a transgenic animal
10/18/2002	WO2004011597A2 Primary nucleotide sequence of the agrotis segetum granulosis viris (asgv), its use in a system to dicover insecticides, and use in prevention and control of agrotis segetum insect pest
10/18/2002	WO2001081401A1 Novel collectins
10/18/2002	CA2445628A1 Primary nucleotide sequence of the agrotis segetum granulosis virus (asgv), insecticide discovery systems containing this sequence and prevention and controlling kits for agrotis segetum insect outbreak and spread
10/17/2002	WO2002082091A2 Method for identification of proteins from intracellular bacteria
10/17/2002	WO2002082087A2 Diagnosis and treatment of enterococcus faecium related disease
10/17/2002	WO2002082081A2 Suppression of androgen receptor transactivation through new pathways to ar and ar coactivators and repressors
10/17/2002	WO2002082077A2 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
10/17/2002	WO2002082075A2 Method for detecting chronic dementia diseases, and corresponding peptides and detection reagents
10/17/2002	WO2002081754A1 Nucleic acid vaccines for prevention of flavivirus infection
10/17/2002	WO2002081747A1 Method of examining steroid responsiveness
10/17/2002	WO2002081745A2 Genes involved in osteogenesis, and methods of use
10/17/2002	WO2002081742A2 Method for the detection of cytochrome b mutations in fungi
10/17/2002	WO2002081731A2 Novel nucleic acids and polypeptides
10/17/2002	WO2002081730A2 Trac1: modulators of lymphocyte activation
10/17/2002	WO2002081726A2 Modulation of gene expression in mouse genetic models of atherosclerosis
10/17/2002	WO2002081722A2 Process for the production of l-amino acids using strains of the family enterobacteriaceae that contain an attenuated acea gene
10/17/2002	WO2002081721A2 Process for the production of l-amino acids using strains of the family enterobacteriaceae that contain an attenuated dgsa gene
10/17/2002	WO2002081720A1 Polysubstituted polycarboxylic phosphoamide biopolymers, methods for their production and uses of compositions derived therefrom
10/17/2002	WO2002081715A1 A transgenic non-human animal having a disruption of at least one allele to the ceacam1 gene and method of making same
10/17/2002	WO2002081713A1 Gene encoding plant protein tm2a, conferring resistance to tomato mosaic virus
10/17/2002	WO2002081709A2 Modified hpv e6 and e7 genes and proteins useful for vaccination
10/17/2002	WO2002081700A1 Proteins involved in multidrug resistance in gram-positives
10/17/2002	WO2002081699A1 Proteins involved in multidrug resistance in gram-positives
10/17/2002	WO2002081698A2 Process for the production of l-amino acids using strains of the family enterobacteriaceae that contain an attenuated frur gene
10/17/2002	WO2002081697A1 Fragment of l. lactis plasmid conferring antiphage activity and uses thereof
10/17/2002	WO2002081696A2 Oryza sativa nuclear cap binding protein 80
10/17/2002	WO2002081695A2 Genes that are modulated by posttranscriptional gene silencing
10/17/2002	WO2002081694A1 Method for the sectetion and production of protein
10/17/2002	WO2002081693A1 Production, composition and usage of a recombinant hormones system for superovulation in vertebrates and invertebrates
10/17/2002	WO2002081692A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/17/2002	WO2002081691A2 Abcg5 and abcg8: compositions and methods of use
10/17/2002	WO2002081690A1 Novel protein, dna thereof and use of the same
10/17/2002	WO2002081689A1 Regulation of human cyclic nucleotide-gated channel ocnc2 subunit
10/17/2002	WO2002081687A2 Yeast genes that affect viral replication
10/17/2002	WO2002081683A2 Protein analysis by means of immobilized arrays of antigens or antibodies
10/17/2002	WO2002081682A1 Novel clock gene promoter
10/17/2002	WO2002081681A1 Novel use of cytokine sf20
10/17/2002	WO2002081676A2 Non-pathogenic bacterial recipient strain of a bacterium containing mycolic acid, method for the production thereof and use of the same
10/17/2002	WO2002081660A1 Compositions and method for enhancing proteoglycan production
10/17/2002	WO2002081657A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/17/2002	WO2002081655A2 Fusion protein construct and method for inducing hiv-specific serum igg and secretory iga antibodies in-vivo
10/17/2002	WO2002081654A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/17/2002	WO2002081649A2 ErbB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF
10/17/2002	WO2002081646A2 Epitope sequences
10/17/2002	WO2002081645A2 Cp27 peptides and their use in modulating cell growth and apoptosis
10/17/2002	WO2002081642A2 Gene brcc-3 and diagnostic and therapeutic uses thereof
10/17/2002	WO2002081641A2 Gene scc-112 and diagnostic and therapeutic uses thereof
10/17/2002	WO2002081640A2 Gene shinc-1 and diagnostic and therapeutic uses thereof
10/17/2002	WO2002081639A2 Gene brcc2 and diagnostic and therapeutic uses thereof
10/17/2002	WO2002081636A2 Protein modification and maintenance molecules
10/17/2002	WO2002081633A2 A bardet-biedl susceptibility gene and uses thereof
10/17/2002	WO2002081629A2 Novel human proteins, polynucleotides encoding them and methods of using the same
10/17/2002	WO2002081625A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/17/2002	WO2002081623A2 Cell cycle nucleic acids, polypeptides and uses thereof
10/17/2002	WO2002081622A2 Plants characterized by enhanced growth and methods and nucleic acid constructs useful for generating same
10/17/2002	WO2002081621A2 Vaccine against the nile fever virus
10/17/2002	WO2002081522A1 Anti-osteopontin antibody and use thereof
10/17/2002	WO2002081521A2 Osteoprotegerin in milk
10/17/2002	WO2002081520A2 Single chain dimeric polypeptides derived from the vegf family
10/17/2002	WO2002081519A2 Ifn-thy fusion protein,dna coding therefore,its preparation and application
10/17/2002	WO2002081518A2 Proteins, polynucleotides encoding them and methods of using the same
10/17/2002	WO2002081517A2 Novel polypeptides and nucleic acids encoded thereby
10/17/2002	WO2002081516A2 Narc10 and narc16, programmed cell death-associated molecules and uses thereof
10/17/2002	WO2002081515A1 Insulin-like growth factor-binding protein
10/17/2002	WO2002081514A2 A novel f-box protein
10/17/2002	WO2002081513A2 Disease-associated protein
10/17/2002	WO2002081512A1 Dust mite der p1 cd8+ t-cell epitopes and uses thereof
10/17/2002	WO2002081511A1 Neurovirulent strain of the west nile virus and applications thereof
10/17/2002	WO2002081510A2 Proteins, polynucleotides encoding them and methods of using the same
10/17/2002	WO2002081509A2 Specific detection of proteolytic enzymes using a hybrid protein
10/17/2002	WO2002081508A2 Use of cd25 binding molecules in steroid-resistant patients
10/17/2002	WO2002081507A2 Interferon gamma polypeptide variants
10/17/2002	WO2002081504A2 Multimerization of hiv-1 vif protein as a therapeutic target
10/17/2002	WO2002081502A2 Methods of crystal optimisation
10/17/2002	WO2002081501A1 Crystals of proteasome-nhibitor complex
10/17/2002	WO2002081500A2 Methods for enhancing a plant stress response
10/17/2002	WO2002081499A2 Somatostatin agonists
10/17/2002	WO2002081498A2 Novel proteins and nucleic acids encoding same
10/17/2002	WO2002081497A2 αξβ3 INTEGRIN-BINDING POLYPEPTIDE MONOBODIES AND THEIR USE
10/17/2002	WO2002081492A1 Human gene critical to fertility
10/17/2002	WO2002081413A2 One dimensional unichemo protection (ucp) in organic synthesis
10/17/2002	WO2002080984A1 Compositions and methods for isolating genes comprising subcellular localization sequences
10/17/2002	WO2002080968A1 Glycoprotein vi and uses thereof
10/17/2002	WO2002080961A1 Isolation of glycoproteins from bovine milk
10/17/2002	WO2002080958A1 Recombination super compound interferon used as hepatitis b surface antigen and e antigen inhibitor
10/17/2002	WO2002080957A1 Adenosine a2a receptor antagonists combined with neurotrophic activity compounds in the treatment of parkinson's disease
10/17/2002	WO2002080955A1 Stimulation of osteogenesis using rank ligand fusion proteins
10/17/2002	WO2002080954A1 Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein
10/17/2002	WO2002080948A1 Compositions and methods for treating inflammation and related conditions
10/17/2002	WO2002080858A2 Use of kpv tripeptide for dermatological disorders
10/17/2002	WO2002080852A2 Genes expressed in intestinal epithelium and peyer's patch m cells
10/17/2002	WO2002080851A2 Chimeric vaccines
10/17/2002	WO2002080849A2 Chemotherapeutic induction of egr-1 promoter activity
10/17/2002	WO2002080848A2 Methods and materials for cancer treatment
10/17/2002	WO2002080845A2 Novel eps8 compounds for therapy and diagnosis and methods for using same
10/17/2002	WO2002080844A2 Novel bgp compounds for therapy and diagnosis and methods for using same
10/17/2002	WO2002080842A2 Medicament and method for diagnosing an autoimmune condition_in particular psoriasis

1 ... 1736 1737 1738 1739 1740 1741 1742 1743 1744 1745 1746 1747 1748 1749 1750 1751 1752 1753 1754 1755 1756 ... 2916